v3.26.3
Other Consolidated Financial Statement - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Collaborative arrangements and non-collaborative arrangement transactions          
Net unrealized (gains) losses recognized on equity securities $ 25.1 $ (3.2) $ (36.8) $ 32.5  
Prepaid Taxes 943.7   943.7   $ 693.6
Other liabilities, noncurrent 668.4   668.4   748.5
Accrued income taxes 179.1   179.1   $ 166.4
Sage and Denali          
Collaborative arrangements and non-collaborative arrangement transactions          
Net unrealized (gains) losses recognized on equity securities   $ 3.8      
Denali Therapeutics          
Collaborative arrangements and non-collaborative arrangement transactions          
Net unrealized (gains) losses recognized on equity securities $ 23.7   $ 42.2 41.9  
Sage Therapeutics          
Collaborative arrangements and non-collaborative arrangement transactions          
Net unrealized (gains) losses recognized on equity securities       $ 23.0